Clinical Trials · NCT01715428
Liraglutide and Cardio-Metabolic Risk Markers
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Palermo
- Enrollment
- 300
- Start date
- Jun 2012
- Locations
- 1 site, Italy
- Primary endpoint
- carotid intima-media thickness